The stock's fall snapped a two-day winning streak.

CVS Health shares powered 7% higher Thursday after the pharmacy and healthcare giant's first-quarter results easily topped ...

CVS HEALTH CORP (CVS) is a large-cap growth stock in the Retail (Drugs) industry. The rating using this strategy is 93% based on the firm’s underlying fundamentals and the stock’s valuation.

CVS’s stock surges toward a one-year high after profit and revenue beat expectations, amid strength in the pharmacy business, ...

Entrance to a CVS Pharmacy in Manhattan. (Photo by ... More Erik McGregor/LightRocket via ) LightRocket via Getty Imag ...

CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better ...

Eli Lilly's stock suffered a nearly 12% loss in markets Thursday despite strong earnings, in what analysts say is an ...

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

CVS Health topped Q1 estimates with $94.59 billion in revenue and raised 2025 EPS outlook to $6.00–$6.20 amid strong Medicare ...